{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:02:57Z","timestamp":1792789377984,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T00:00:00Z","timestamp":1520812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s12519-018-0125-y","type":"journal-article","created":{"date-parts":[[2018,3,12]],"date-time":"2018-03-12T14:41:11Z","timestamp":1520865671000},"page":"121-126","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Calcineurin inhibitors and nephrotoxicity in children"],"prefix":"10.1007","volume":"14","author":[{"given":"Fei","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Hua","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,12]]},"reference":[{"key":"125_CR1","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/337473a0","volume":"337","author":"N Takahashi","year":"1989","unstructured":"Takahashi N, Hayano T, Suzuki M. Peptidylprolyl cis-trans isomerase is the cyclosporin a-binding protein cyclophilin. Nature. 1989;337:473\u20135.","journal-title":"Nature"},{"key":"125_CR2","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1038\/341758a0","volume":"341","author":"M Harding","year":"1989","unstructured":"Harding MW, Galat A, Uehling DE, Schreiber SL. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989;341:758\u201360.","journal-title":"Nature"},{"key":"125_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1038\/337476a0","volume":"337","author":"G Ischer","year":"1989","unstructured":"Fischer G, Wittmann-Liebold B, Lang K, Kiefhaber T, Schmid FX. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 1989;337:476\u20138.","journal-title":"Nature"},{"key":"125_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1038\/352803a0","volume":"352","author":"WM Flanagan","year":"1991","unstructured":"Flanagan WM, Corth\u00e9sy B, Bram RJ, Crabtree GR. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosproine A. Nature. 1991;352:803\u20137.","journal-title":"Nature"},{"key":"125_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/357695a0","volume":"357","author":"N Clipstone","year":"1992","unstructured":"Clipstone NA, Crabtree GR. Identification of caalcineurin as a key signalling enzyme in T-lymphocyte activation. Nature. 1992;357:695\u20137.","journal-title":"Nature"},{"key":"125_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/365352a0","volume":"365","author":"J Jain","year":"1993","unstructured":"Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, et al. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 1993;365:352\u20135.","journal-title":"Nature"},{"key":"125_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/ki.1996.415","volume":"50","author":"W Bennett","year":"1996","unstructured":"Bennett WM, DeMattos A, Meyer MM, Andoh T, Barry JM. Chronic cyclosporine nephropathy: the Achilles\u2019 heel of immunosuppressive therapy. Kidney Int. 1996;50:1089\u2013100.","journal-title":"Kidney Int"},{"key":"125_CR8","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1097\/00007890-199812270-00029","volume":"66","author":"K Solez","year":"1998","unstructured":"Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopies from a U.S. multicenter kidney transplant trial comparing tarcolimus versus cyslosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation. 1998;66:1736\u201340.","journal-title":"Transplantation"},{"key":"125_CR9","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","volume":"4","author":"M Naesens","year":"2009","unstructured":"Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4:481\u2013508.","journal-title":"Clin J Am Soc Nephrol."},{"key":"125_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1159\/000351648","volume":"37","author":"N Issa","year":"2013","unstructured":"Issa N, Kukla A, Ibrahim HN. Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol. 2013;37:602\u201312.","journal-title":"Am J Nephrol"},{"key":"125_CR11","first-page":"1287","volume":"4","author":"N Swerkova","year":"2003","unstructured":"Swerkova N, Crhristians U. Transplantation: toxicokinetics and mechanisms of toxicity of cyclosporine and macrolides. Curr Opin Investig Drugs. 2003;4:1287\u201396.","journal-title":"Curr Opin Investig Drugs"},{"key":"125_CR12","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/adc.2005.080960","volume":"91","author":"S Fujinaga","year":"2006","unstructured":"Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y. Idependent risk factors for chronic cysporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child. 2006;91:666\u201370.","journal-title":"Arch Dis."},{"key":"125_CR13","doi-asserted-by":"publisher","first-page":"136","DOI":"10.5539\/gjhs.v8n4p136","volume":"8","author":"SR Shah","year":"2016","unstructured":"Shah SR, Altaf A, Arshad MH, Mari A, Noorani S, Saeed E, et al. Use of cyclosporine therapy in steroid resistant nephrotic syndrome (SRNS): a review. Glob J Health Sci. 2016;8:136\u201341.","journal-title":"Glob J Health Sci."},{"key":"125_CR14","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/archdischild-2015-308924","volume":"101","author":"N Larkins","year":"2016","unstructured":"Larkins N, Kim S, Craig J, Hodson E. Steroid-sensitive nephrotic syndrome: an evidence-based update of immunosuppressive treatment in children. Arch Dis Child. 2016;101:404\u20138.","journal-title":"Arch Dis Child"},{"key":"125_CR15","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","volume":"8","author":"P Tarshish","year":"1997","unstructured":"Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr. Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol. 1997;8:769\u201376.","journal-title":"J Am Soc Nephrol."},{"key":"125_CR16","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2215\/CJN.05691108","volume":"4","author":"H Kyrieleis","year":"2009","unstructured":"Kyrieleis HA, L\u00f6wik MM, Pronk I, Cruysberg HR, Kremer JA, Oyen WJ, et al. Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children. Clin J Am Soc Nephrol. 2009;4:1593\u2013600.","journal-title":"Clin J Am Soc Nephrol."},{"key":"125_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1586\/ecp.10.31","volume":"3","author":"J Oh","year":"2010","unstructured":"Oh J, Kemper MJ. Second-line options for refractory steroid-senstive and -resistant nephrotic syndrome. Expert Rev Clin Pharmacol. 2010;3:527\u201337.","journal-title":"Expert Rev Clin Pharmacol."},{"key":"125_CR18","first-page":"853","volume":"21","author":"H Dieperink","year":"1985","unstructured":"Dieperink H, Starklint H, Leyssac PP, Kemp E. Glomerulotublar function in cyclosporine-treated rats. A lithium clearance, occlusion time\/transit time and micropuncture study. Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1985;21:853\u20139.","journal-title":"Proc Eur Dial Transpl Assoc Eur Ren Assoc"},{"key":"125_CR19","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/ki.1985.196","volume":"28","author":"B Murray","year":"1985","unstructured":"Murray BM, Paller MS, Ferris TF. Effect of cyclosporine administration on renal hemodynamics in conscious reats. Kidney Int. 1985;28:767\u201374.","journal-title":"Kidney Int"},{"key":"125_CR20","doi-asserted-by":"publisher","first-page":"F2","DOI":"10.1152\/ajprenal.00072.2007","volume":"293","author":"N Bobadilla","year":"2007","unstructured":"Bobadilla NA, Gamba G. New insight into the pathophysiology of cyclosporine nephrotoxicity: a role of aldosterone. Am J Physiol Renal Physiol. 2007;293:F2\u20139.","journal-title":"Am J Physiol Renal Physiol"},{"key":"125_CR21","first-page":"356","volume":"49","author":"M Mihatsch","year":"1998","unstructured":"Mihatsch MJ, Kyo M, Morozumi K, Yamaguchi Y, Nickeleit V, Ryffel B. The side-effects of cyclosporine-A and tacrolimus. Clin Nephrol. 1998;49:356\u201363.","journal-title":"Clin Nephrol"},{"key":"125_CR22","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1111\/j.1523-1755.2004.00627.x","volume":"65","author":"K Hocherl","year":"2004","unstructured":"H\u00f6cherl K, Kees F, Kr\u00e4mer BK, Kurtz A. Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal cox-2 expression. Kidney Int. 2004;65:2071\u201380.","journal-title":"Kidney Int"},{"key":"125_CR23","first-page":"580","volume":"16","author":"CC Lin","year":"2003","unstructured":"Lin CC, King KL, Chao YW, Yang AH, Chang CF, Yang WC. Tacrolimus-associated hemolytic uremic syndrome: a case analysis. J Nephrol. 2003;16:580\u20135.","journal-title":"J Nephrol."},{"key":"125_CR24","first-page":"580","volume":"16","author":"A Bren","year":"2005","unstructured":"Bren A, Pajek J, Grego K, Buturovic J, Ponikvar R, Lindic J, et al. Follow-up of kidney graft recipients with cyclosporine-associated hemolytic-uremic syndrome and thrombotic microangiopathy. Transplant Proc. 2005;37:1889\u201391.","journal-title":"J Nephrol."},{"key":"125_CR25","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5414\/CNP67335","volume":"2007","author":"Ponticelli C Ponticelli","year":"2007","unstructured":"Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol. 2007;67:335\u201340.","journal-title":"Clin Nephrol"},{"key":"125_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJM198409133111103","volume":"311","author":"B Myers","year":"1984","unstructured":"Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984;311:699\u2013705.","journal-title":"N Engl J Med"},{"key":"125_CR27","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1046\/j.1523-1755.2002.00668.x","volume":"62","author":"A Khanna","year":"2002","unstructured":"Khanna A, Plummer M, Bromberek C, Bresnahan B, Hariharan S. Expression of TGF-beta and fibrogenic genes in transplant recipients with tacrolimus and cyclosporine nephrotoxicity. Kidney Int. 2002;62:2257\u201363.","journal-title":"Kidney Int"},{"key":"125_CR28","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1681\/ASN.2005080891","volume":"17","author":"MC Ross-Van Groningen","year":"2006","unstructured":"Roos-van Groningen MC, Scholten EM, Lelieveld PM, Rowshani AT, Baelde HJ, Bajema IM. Molecular comparison of calcineuin inhibitor-induced fibrogenic responses in protocol renal transplant biopsies. J Am Soc Nephrol. 2006;17:881\u20138.","journal-title":"J Am Soc Nephrol."},{"key":"125_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0002-9440(10)62984-7","volume":"167","author":"C Slattery","year":"2005","unstructured":"Slattery C, Campbell E, McMorrow T, Ryan MP. Cyclosporine A-induced renal fibrosis: a role for epithelial mesenchymal transition. Am J Pathol. 2005;167:395\u2013407.","journal-title":"Am J Pathol"},{"key":"125_CR30","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/j.1600-6143.2006.01559.x","volume":"6","author":"A Hertig","year":"2006","unstructured":"Hertig A, Verine J, Mougenot B, Jouanneau C, Ouali N, Sebe P. Risk factor for early epithelial to mesenchymal transition in renal grafts. Am J Transpl. 2006;6:2937\u201346.","journal-title":"Am J Transpl"},{"key":"125_CR31","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/ki.1997.380","volume":"52","author":"F Shihab","year":"1997","unstructured":"Shihab FS, Bennett WM, Tanner AM, Andoh TF. Angiotensin ii blockade decreases TGF-beta1 and matrix proteins in cyclosporine nephropathy. Kidney Int. 1997;52:660\u201373.","journal-title":"Kidney Int"},{"key":"125_CR32","doi-asserted-by":"publisher","first-page":"7201","DOI":"10.4049\/jimmunol.0801772","volume":"182","author":"S Du","year":"2009","unstructured":"Du S, Hiramatsu N, Hayakawa K, Kasai A, Okamura M, Huang T, et al. Suppression of NF-kappaB by cyclosporine a and tacrolimus (FK506) via induction of the C\/EBP family: implication for unfolded protein response. J Immunol. 2009;182:7201\u201311.","journal-title":"J Immunol"},{"key":"125_CR33","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1111\/j.1600-6143.2011.03719.x","volume":"11","author":"M Mengel","year":"2011","unstructured":"Mengel M, Mihatsch M, Halloran PF. Histological characteristics of calcineurin inhibitor toxcity-there is no such thing as specificity! Am J Transplant. 2011;11:2549\u201350.","journal-title":"Am J Transpl"},{"key":"125_CR34","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1007\/s00467-012-2228-3","volume":"27","author":"W Wang","year":"2012","unstructured":"Wang W, Xia Y, Mao J, Chen Y, Wang D, Shen H, et al. Treatment of tacrolimus or cyclosporine A in children with idiopathic nephrotic syndrome. Pediatr Nephrol. 2012;27:2073\u20139.","journal-title":"Pediatr Nephrol."},{"key":"125_CR35","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1097\/TP.0000000000001243","volume":"100","author":"BJ Nankivell","year":"2016","unstructured":"Nankivell BJ, P\u2019Ng CH, O\u2019Connell PJ, Chapman JR. Calcineurin inhibitor nephrotoxicity through the lens of longitudinal histology: comparison of cyclosporine and tacrolimus eras. Transplantation. 2016;100:1723\u201331.","journal-title":"Transplantation"},{"key":"125_CR36","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1007\/s00467-009-1220-z","volume":"24","author":"L Butani","year":"2009","unstructured":"Butani L, Ramsamooj R. Experience with tacrolimus in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2009;24:1517\u201323.","journal-title":"Pediatr Nephrol."},{"key":"125_CR37","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00467-015-3133-3","volume":"30","author":"A Jahan","year":"2015","unstructured":"Jahan A, Prabha R, Chaturvedi S, Mathew B, Fleming D, Agarwal I. Clinical efficacy and pharmacokinetics of tacrolimus in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2015;30:1961\u20137.","journal-title":"Pediatr Nephrol."},{"key":"125_CR38","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12519-015-0062-y","volume":"12","author":"EM Yang","year":"2016","unstructured":"Yang EM, Lee ST, Choi HJ, Cho HY, Lee JH, Kang HG, et al. Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of tacrobell(r), a generic formula. World J Pediatr. 2016;12:60\u20135.","journal-title":"World J Pediatr."},{"key":"125_CR39","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1159\/000097864","volume":"26","author":"R Bhimma","year":"2006","unstructured":"Bhimma R, Adhikari M, Asharam K, Connolly C. Management of steroid-resistant focal segmental glomerulosclerosis in children using tacrolimus. Am J Nephrol. 2006;26:544\u201351.","journal-title":"Am J Nephrol"},{"key":"125_CR40","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.1093\/ndt\/gfq813","volume":"26","author":"C Morgan","year":"2011","unstructured":"Morgan C, Sis B, Pinsk M, Yiu V. Renal interstitial fibrosis in children treated with FK506 for nephrotic syndrome. Nephrol Dial Transplant. 2011;26:2860\u20135.","journal-title":"Nephrol Dial. Transpl."},{"key":"125_CR41","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1097\/01.tp.0000190423.82154.01","volume":"81","author":"BJ Nankivell","year":"2006","unstructured":"Nankivell BJ, Chapman JR. Chronic allograft nephropathy: current concepts and future directions. Transplantation. 2006;81:643\u201354.","journal-title":"Transplantation"},{"key":"125_CR42","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2215\/CJN.01320406","volume":"2","author":"N Kambham","year":"2007","unstructured":"Kambham N, Nagarajan S, Shah S, Li L, Salvatierra O, Sarwal MM. A novel, semiquantitative, clinically correlated calcineurin inhibitor toxicity score for renal allograft biopsies. Clin J Am Soc Nephrol. 2007;2:135\u201342.","journal-title":"Clin J Am Soc Nephrol."},{"key":"125_CR43","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","volume":"8","author":"K Solez","year":"2008","unstructured":"Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008;8:753\u201360.","journal-title":"Am J Transpl"},{"key":"125_CR44","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1111\/j.1600-6143.2010.03240.x","volume":"10","author":"R Mannon","year":"2010","unstructured":"Mannon RB, Matas AJ, Grande J, Leduc R, Connett J, Kasiske B, et al. Inflammation in areas of tubular atrophy in kidney allogrft biopsies: a potent predictor of allograft failure. Am J Transplant. 2010;10:2066\u201373.","journal-title":"Am J Transplant"},{"key":"125_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1097\/00007890-199907270-00013","volume":"68","author":"M Nicholson","year":"1999","unstructured":"Nicholson ML, Bailey E, Williams S, Harris KP, Furness PN. Computerized histomorphometric assessment of protocol renal transplant biopsy specimens for surrogate markers of chronic rejection. Transplantation. 1999;68:236\u201341.","journal-title":"Transplantation"},{"key":"125_CR46","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1097\/01.ASN.0000066143.02832.5E","volume":"14","author":"P Grimm","year":"2003","unstructured":"Grimm PC, Nickerson P, Gough J, McKenna R, Stern E, Jeffery J, et al. Computerized image analysis of Sirius Red-stained renal allograft biopsies as a surrogate marker to predict long-term allograft function. J Am Soc Nephrol. 2003;14:1662\u20138.","journal-title":"J Am Soc Nephrol."},{"key":"125_CR47","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1681\/ASN.2015050601","volume":"27","author":"V Vuiblet","year":"2016","unstructured":"Vuiblet V, Fere M, Gobinet C, Birembaut P, Piot O, Rieu P. Renal graft fibrosis and inflammation quantification by an automated fourier-transform infrared imaging technique. J Am Soc Nephrol. 2016;27:2382\u201391.","journal-title":"J Am Soc Nephrol."},{"key":"125_CR48","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.taap.2008.01.019","volume":"229","author":"N Pallet","year":"2008","unstructured":"Pallet N, Rabant M, Xu-Dubois YC, Lecorre D, Mucchielli MH, Imbeaud S, et al. Response of tubular cells to cyclosporine and sirolimus: a toxicogenomic study. Toxicol Appl Pharmacol. 2008;229:184\u201396.","journal-title":"Toxicol Appl Pharmacol"},{"key":"125_CR49","doi-asserted-by":"publisher","first-page":"142521","DOI":"10.1155\/2015\/142521","volume":"2015","author":"D Cosner","year":"2015","unstructured":"Cosner D, Zeng X, Zhang PL. Proximal tubular injury in medullary rays is an early sign of acute tacrolimus nephrotoxicity. J Transplant. 2015;2015:142521.","journal-title":"J Transplant."},{"key":"125_CR50","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/gb-2005-6-7-226","volume":"6","author":"P Wang","year":"2005","unstructured":"Wang P, Heitman J. The cyclophilins. Genome Biol. 2005;6:226.","journal-title":"Genome Biol."},{"key":"125_CR51","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/1354750X.2013.790074","volume":"18","author":"YS Bao","year":"2013","unstructured":"Bao YS, Ji Y, Zhao SL, Ma LL, Xie RJ, Na SP. Serum levels and activity of indoleamine2,3-dioxygenase and tryptophanyl-tRNA synthetase and their association with disease severity in patients with chronic kidney disease. Biomarkers. 2013;18:379\u201385.","journal-title":"Biomarkers"},{"key":"125_CR52","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.ajpath.2010.10.009","volume":"178","author":"N Kato","year":"2011","unstructured":"Kato N, Kosugi T, Sato W, Ishimoto T, Kojima H, Sato Y, et al. Basigin\/CD147 promotes renal fibrosis after unilateral ureteral obstruction. Am J Pathol. 2011;178:572\u20139.","journal-title":"Am J Pathol"},{"key":"125_CR53","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2165\/11538530-000000000-00000","volume":"13","author":"B H\u00f6cker","year":"2011","unstructured":"H\u00f6cker B, T\u00f6nshoff B. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option? Paediatr Drugs. 2011;13:49\u201369.","journal-title":"Pediatr Drugs."},{"key":"125_CR54","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1432-2277.2000.tb01067.x","volume":"13","author":"G Filler","year":"2000","unstructured":"Filler G, Gellermann J, Zimmering M, Mai I. Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity. Transpl Int. 2000;13:201\u20136.","journal-title":"Transpl Int."},{"key":"125_CR55","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1034\/j.1399-3046.2001.00007.x","volume":"5","author":"E David-neto","year":"2001","unstructured":"David-Neto E, Araujo LM, Lemos FC, David DS, Mazzucchi E, Nahas WC, et al. Introduction of mycophenolate mofetil and cyclosporin reduction in children with chronic transplant nephropathy. Pediatr Transplant. 2001;5:302\u20139.","journal-title":"Pediatr Transpl"},{"key":"125_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1399-3046.2008.01031.x","volume":"13","author":"L Krischock","year":"2009","unstructured":"Krischock L, Gullett A, Bockenhauer D, Rees L, Trompeter RS, Marks SD. Calcineurin-inhibitor free immunosuppression with mycophenolate mofetil and corticosteroids in paediatric renal transplantation improves renal allograft function without increasing acute rejection. Pediatr Transplant. 2009;13:475\u201381.","journal-title":"Pediatr Transpl"},{"key":"125_CR57","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/01.tp.0000260146.57898.9c","volume":"83","author":"K Cransberg","year":"2007","unstructured":"Cransberg K, Cornelissen M, Lilien M, Van Hoeck K, Davin JC, Nauta J. Maintenance immunosuppression with mycophenolate mofetil and corticosteroids in pediatric kidney transplantation: temporary benefit but not without risk. Transplantation. 2007;83:1041\u20137.","journal-title":"Transplantation"},{"key":"125_CR58","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1681\/ASN.2006010049","volume":"17","author":"W Harmon","year":"2006","unstructured":"Harmon W, Meyers K, Ingelfinger J, McDonald R, McIntosh M, Ho M, et al. Safety and efficacy of a calcineurin inhibitor avoidance regimen in pediatric renal transplantation. J Am Soc Nephrol. 2006;17:1735\u201345.","journal-title":"J Am Soc Nephrol."},{"key":"125_CR59","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/j.1399-3046.2006.00526.x","volume":"10","author":"B Hocker","year":"2006","unstructured":"H\u00f6cker B, Feneberg R, K\u00f6pf S, Weber LT, Waldherr R, W\u00fchl E, et al. SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity. Pediatr Transplant. 2006;10:593\u2013601.","journal-title":"Pediatr Transpl."},{"key":"125_CR60","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1399-3046.2008.00906.x","volume":"12","author":"LC Hymes","year":"2008","unstructured":"Hymes LC, Warshaw BL, Amaral SG, Greenbaum LA. Tacrolimus withdrawal and conversion to sirolimus at three months post-pediatric renal transplantation. Pediatr Transplant. 2008;12:773\u20137.","journal-title":"Pediatr Transpl."},{"key":"125_CR61","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1007\/s00467-007-0571-6","volume":"22","author":"HR Powell","year":"2007","unstructured":"Powell HR, Kara T, Jones CL. Early experience with conversion to sirolimus in a pediatric renal transplant population. Pediatr Nephrol. 2007;22:1773\u20137.","journal-title":"Pediatr Nephrol."},{"key":"125_CR62","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1111\/j.1399-3046.2006.00503.x","volume":"10","author":"J Falger","year":"2006","unstructured":"Falger JC, Mueller T, Arbeiter K, Boehm M, Regele H, Balzar E, et al. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy. Pediatr Transplant. 2006;10:565\u20139.","journal-title":"Pediatr Transpl."},{"key":"125_CR63","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/j.1399-3046.2007.00749.x","volume":"11","author":"J Ibanez","year":"2007","unstructured":"Ib\u00e1\u00f1ez JP, Monteverde ML, Diaz MA, Goldberg J, Turconi AF. Sirolimus in chronic allograft nephropathy in pediatric recipients. Pediatr Transplant. 2007;11:770\u201380.","journal-title":"Pediatr Transplant"},{"key":"125_CR64","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1399-3046.2007.00847.x","volume":"12","author":"L Weintraub","year":"2008","unstructured":"Weintraub L, Li L, Kambham N, Alexander S, Concepcion W, Miller K, et al. Patient selection critical for calcineurin inhibitor withdrawal in pediatric kidney transplantation. Pediatr Transplant. 2008;12:541\u20139.","journal-title":"Pediatr Transpl"},{"key":"125_CR65","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.transproceed.2016.02.024","volume":"48","author":"AC Alvarez-Elias","year":"2016","unstructured":"Alvarez-Elias AC, Garcia-Roca P, Vel\u00e1squez-Jones L, Valverde S, Varela-Fascinetto G, Medeiros M. Cyp3A5 genotype and time to reach tacrolimus therapeutic levels in renal transplant children. Transplant Proc. 2016;48:631\u20134.","journal-title":"Transpl Proc."},{"key":"125_CR66","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.aju.2012.02.003","volume":"10","author":"N Issa","year":"2012","unstructured":"Issa N, Kukla A, Ibrahim HN. The over-exaggerated chronic nephrotoxicity of calcineurin inhibitors. Arab J Urol. 2012;10:169\u201374.","journal-title":"Arab J Urol."},{"key":"125_CR67","doi-asserted-by":"publisher","first-page":"7","DOI":"10.5500\/wjt.v3.i2.7","volume":"3","author":"M Salvadori","year":"2013","unstructured":"Salvadori M, Bertoni E. Is it time to give up with calcineurin inhibitors in kidney transplantation? World J Transplant. 2013;3:7\u201325.","journal-title":"World J Transplant."}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-018-0125-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-018-0125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-018-0125-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T21:40:07Z","timestamp":1660599607000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-018-0125-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,12]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["125"],"URL":"https:\/\/doi.org\/10.1007\/s12519-018-0125-y","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,12]]},"assertion":[{"value":"16 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ethical approval was issued by the Research Ethics Committee of The Children Hospital of Zhejiang University School of Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}